Metastasis-associated protein MTA2 is a protein that in humans is encoded by the MTA2gene.
This gene encodes a protein that has been identified as a component of NuRD, a nucleosome remodeling deacetylase complex identified in the nucleus of human cells. It shows a very broad expression pattern and is strongly expressed in many tissues. It may represent one member of a small gene family that encode different but related proteins involved either directly or indirectly in transcriptional regulation. Their indirect effects on transcriptional regulation may include chromatin remodeling. It is closely related to another member of this family, a protein that has been correlated with the metastatic potential of certain carcinomas. These two proteins are so closely related that they share the same types of domains. These domains include two DNA binding domains, a dimerization domain, and a domain commonly found in proteins that methylate DNA. One of the proteins known to be a target protein for this gene product is p53. Deacteylation of p53 is correlated with a loss of growth inhibition in transformed cells supporting a connection between these gene family members and metastasis.
^Futamura M, Nishimori H, Shiratsuchi T, Saji S, Nakamura Y, Tokino T (Mar 1999). "Molecular cloning, mapping, and characterization of a novel human gene, MTA1-L1, showing homology to a metastasis-associated gene, MTA1". J Hum Genet44 (1): 52–6. doi:10.1007/s100380050107. PMID9929979.
^ abYasui, Dag; Miyano Masaru, Cai Shutao, Varga-Weisz Patrick, Kohwi-Shigematsu Terumi (Oct 2002). "SATB1 targets chromatin remodelling to regulate genes over long distances". Nature (England) 419 (6907): 641–5. doi:10.1038/nature01084. ISSN0028-0836. PMID12374985.Cite uses deprecated parameters (help)
^Hakimi, Mohamed-Ali; Dong Yuanshu; Lane William S; Speicher David W; Shiekhattar Ramin (Feb 2003). "A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes". J. Biol. Chem. (United States) 278 (9): 7234–9. doi:10.1074/jbc.M208992200. ISSN0021-9258. PMID12493763.
^Sakai, Hirotaka; Urano Takeshi; Ookata Kayoko; Kim Mi-Hyun; Hirai Yugo; Saito Motoki; Nojima Yoshihisa; Ishikawa Fuyuki (Dec 2002). "MBD3 and HDAC1, two components of the NuRD complex, are localized at Aurora-A-positive centrosomes in M phase". J. Biol. Chem. (United States) 277 (50): 48714–23. doi:10.1074/jbc.M208461200. ISSN0021-9258. PMID12354758.
^Saito, Motoki; Ishikawa Fuyuki (Sep 2002). "The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2". J. Biol. Chem. (United States) 277 (38): 35434–9. doi:10.1074/jbc.M203455200. ISSN0021-9258. PMID12124384.
Zhang Y, LeRoy G, Seelig HP, et al. (1998). "The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.". Cell95 (2): 279–89. doi:10.1016/S0092-8674(00)81758-4. PMID9790534.
Tong JK, Hassig CA, Schnitzler GR, et al. (1998). "Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex.". Nature395 (6705): 917–21. doi:10.1038/27699. PMID9804427.
Xue Y, Wong J, Moreno GT, et al. (1999). "NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.". Mol. Cell2 (6): 851–61. doi:10.1016/S1097-2765(00)80299-3. PMID9885572.
Wade PA, Gegonne A, Jones PL, et al. (1999). "Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.". Nat. Genet.23 (1): 62–6. doi:10.1038/12664. PMID10471500.
Luo J, Su F, Chen D, et al. (2000). "Deacetylation of p53 modulates its effect on cell growth and apoptosis.". Nature408 (6810): 377–81. doi:10.1038/35042612. PMID11099047.
Humphrey GW, Wang Y, Russanova VR, et al. (2001). "Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1.". J. Biol. Chem.276 (9): 6817–24. doi:10.1074/jbc.M007372200. PMID11102443.
Saito M, Ishikawa F (2002). "The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.". J. Biol. Chem.277 (38): 35434–9. doi:10.1074/jbc.M203455200. PMID12124384.
Yasui D, Miyano M, Cai S, et al. (2002). "SATB1 targets chromatin remodelling to regulate genes over long distances.". Nature419 (6907): 641–5. doi:10.1038/nature01084. PMID12374985.
Hakimi MA, Dong Y, Lane WS, et al. (2003). "A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes.". J. Biol. Chem.278 (9): 7234–9. doi:10.1074/jbc.M208992200. PMID12493763.
Yao YL, Yang WM (2004). "The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity.". J. Biol. Chem.278 (43): 42560–8. doi:10.1074/jbc.M302955200. PMID12920132.
Zoltewicz JS, Stewart NJ, Leung R, Peterson AS (2004). "Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesis.". Development131 (1): 3–14. doi:10.1242/dev.00908. PMID14645126.
Jiang CL, Jin SG, Pfeifer GP (2005). "MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.". J. Biol. Chem.279 (50): 52456–64. doi:10.1074/jbc.M409149200. PMID15456747.